NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy. Lyon (FR): International Agency for Research on Cancer; 2007. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 91.)
Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy.
Show detailsAnnex 4 lists the composition of brands of combined hormonal menopausal therapy preparations that are used continuously (Table 1) or sequentially (Table 2).
Table 2
Combined sequential preparations.
Table 1
Combined continuous preparations.
References
- Sturdee, D.W. (2004) The Facts of Hormone Therapy for Menopausal Women, London, The Parthenon Publishing Group, pp. 37–51, 174–180
- Annex 4. Estrogen-Progestogen Therapies - Combined Estrogen–Progestogen Contrace...Annex 4. Estrogen-Progestogen Therapies - Combined Estrogen–Progestogen Contraceptives and Combined Estrogen–Progestogen Menopausal Therapy
- Homo sapiens isolate CHM13 chromosome 4, alternate assembly T2T-CHM13v2.0Homo sapiens isolate CHM13 chromosome 4, alternate assembly T2T-CHM13v2.0gi|2194974292|gnl|ASM:GCF_009914825 f|NC_060928.1||gpp|GPC_000012743.1||gnl|NCBI_GENOMES|119564Nucleotide
- Schizosaccharomyces pombe protein Mil1 (mil1), partial mRNASchizosaccharomyces pombe protein Mil1 (mil1), partial mRNAgi|67999644|ref|NM_001019028.1|Nucleotide
- GEO Profile Links for Gene (Select 2543150) (8)GEO Profiles
- PREDICTED: Homo sapiens YJU2 splicing factor homolog B (YJU2B), transcript varia...PREDICTED: Homo sapiens YJU2 splicing factor homolog B (YJU2B), transcript variant X2, mRNAgi|2217323262|ref|XM_047439475.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...